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Abstract
The overlap of 94 single-nucleotide polymorphisms (SNP) among the 4,720 and 11,120 SNPs
contained in the linkage panels of Illumina and Affymetrix, respectively, allows an assessment of the
discrepancy rate produced by these two platforms. Although the no-call rate for the Affymetrix
platform is approximately 8.6 times greater than for the Illumina platform, when both platforms
make a genotypic call, the agreement is an impressive 99.85%. To determine if disputed genotypes
can be resolved without sequencing, we studied recombination in the region of the discrepancy for
the most discrepant SNP rs958883 (typed by Illumina) and tsc02060848 (typed by Affymetrix). We
find that the number of inferred recombinants is substantially higher for the Affymetrix genotypes
compared to the Illumina genotypes. We illustrate this with pedigree 10043, in which 3 of 7 versus
0 of 7 offspring must be double recombinants using the genotypes from the Affymetrix and the
Illumina platforms, respectively. Of the 36 SNPs with one or more discrepancies, we identified a
subset that appears to cluster in families. Some of this clustering may be due to the presence of a
second segregating SNP that obliterates a XbaI site (the restriction enzyme used in the Affymetrix
platform), resulting in a fragment too long (>1,000 bp) to be amplified.
Background
All markers are not created equal with respect to informa-
tion content, ease of genotyping, or the frequency of mis-
calls.
Genotyping errors are a source of concern in both linkage
and association analyses. In a linkage study it is generally
easier to detect genotyping errors for microsatellites than
for single-nucleotide polymorphisms (SNPs) because
microsatellite errors are more likely to give rise to Mende-
lian inheritance incompatibilities. However, because
SNPs are primarily diallelic, genotyping errors often do
not give rise to a Mendelian transmission inconsistency.
Indeed, in some settings such as a linkage study of affected
sibships, it is impossible to detect genotyping errors for
individual SNP markers if parents are not genotyped.
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In this study we compare the genotypic calls reported by
two competing SNP platforms: Illumina and Affymetrix.
We identified 91 autosomal and 3 X-linked SNPs that are
common to both datasets.
Methods and Results
Because the allele designations are arbitrary, we decided
to use the Illumina designations as our template. In the
Affymetrix data, 50 of the 94 SNPs used the same allele
designations as Illumina. For the remaining 44 SNPs, we
relabeled the alleles to achieve comparability.
Table 1 compares the allele calls for the two platforms for
the 94 SNPs using all of the Collaborative Study on the
Genetics of Alcoholism (COGA) data. The numbers in
parentheses are the counts prior to data cleaning. As
expected, the number of no-calls increased in the clean
data as a result of removing Mendelian incompatibilities.
For the 116,457 occurrences in which a genotype call
could be made with both platforms, a total of 180
(0.15%) are discrepant. None of these discrepancies gives
rise to a Mendelian non-inheritance, in part because of the
data cleaning process that selectively removed an "offend-
ing" genotype.
The no-call rate is higher for the Affymetrix platform than
for the Illumina platform. In the cleaned data for these 94
SNPs, the difference in the no-call rate is approximately
8.6-fold. There is, however, an interesting pattern in the
distribution of no-calls. The Affymetrix no-call rate is
3.79% for genotypes that Illumina calls as homozygous
and 6.53% for genotypes that Illumina calls heterozygous.
The difference in call rates conditioned on Illumina's gen-
otypes is highly significant (p < 0.0001). This patterning is
not present for Illumina no-calls.
The distribution of the 180 discrepancies is also nonran-
dom. There are no occurrences of one platform calling a
genotype a homozygote and the other platform calling the
genotype the opposite homozygote. Rather, all of the dis-
crepancies result from a genotype being called
homozygous by one platform and heterozygous by the
other. In 86% of the discrepancies, Illumina calls the gen-
otype heterozygous and Affymetrix calls it homozygous.
There are no discrepancies for 58 (62%) of the 94 SNPs
(Table 2). For 14 SNPs, there is a single discrepancy. For
Table 1: Joint distribution of genotypes produced by the Illumina and Affymetrix platforms.
Illumina Affymetrix
0/0a 1/1 1/2 2/2 Total
0/0a 106 (55) 183 (181) 261 (257) 176 (172) 726 (665)
1/1 1415 (1395) 31993 (32188) 5 (7) 0 (0) 33413 (33590)
1/2 3562 (3544) 38 (50) 50816 (51098) 116 (137) 54532 (54829)
2/2 1168 (1156) 0 (0) 21 (28) 33468 (33624) 34657 (34808)
Total 6251 (6150) 32214 (32419) 51103 (51390) 33760 (33933) 123328 (123892)
The numbers in parentheses are from the data that include errors due to Mendelian incompatibility.
a0/0 denotes missing genotypes (no-calls).
Table 2: Frequency distribution for discrepancies in 94 SNPs 
genotyped in both Illumina and Affymetrix linkage panels.
Number of 
Discrepancies
Frequency Familiala Uniqueb
05 8- -
11 4- -
26 2  ( 2 ) 8
35 1  ( 3 ) 1 2
4 2 1(2),1(4) 2
51 5
6 1 1(2) 4
9 2 2(2),1(3) 11
12 1 2(2),2(4) 0
16 1 5(2) 6
17 1 1(2),1(3) 12
21 1 2(2),1(4),1(5),1
(6)
2
36 1 4(2),4(3),2(4) 8
aThe number of different families and the number of persons in the 
family (in parentheses) that show the discrepancy.
bThe number of families with just one discrepancy.BMC Genetics 2005, 6:S152
Page 3 of 5
(page number not for citation purposes)
the remaining 22 SNPs, there are 2 or more discrepancies.
For 8 of these 22 SNPs with multiple discrepancies, there
is no evidence for family clustering. For the remaining 14
SNPs, however, the discrepancies give evidence of cluster-
ing in families. In almost every intra-familial discrepancy
(83 out of 88 occurrences), the Illumina assay calls the
genotype heterozygous.
Two methods are commonly used to check for the pres-
ence of genotyping errors. The first – especially useful in
case/control association studies – is to determine if more
than the expected number of markers are out of Hardy-
Weinberg equilibrium (HWE). The second method,
appropriate for family data, is to determine if double
recombinants can be inferred over a short genomic
region.
We performed a HWE assessment of the 34 autosomal
SNPs that showed one or more discrepancies between the
two platforms. This assessment was performed on a panel
of 245 unrelated Whites drawn from the COGA families.
None of the 34 SNPs from the Illumina platform was sig-
nificantly out of equilibrium. Four of the 34 SNPs from
the Affymetrix platform were found not to be in HWE
(tsc0546488,  p  < 0.0001; tsc1018661, p  = 0.014;
tsc0039689, p = 0.023; tsc0280570, p = 0.022). None of
these departures from HWE proportions is due to discrep-
ancies in allele calling, however, because the number of
discrepancies for tsc0546488, tsc1018661, tsc0039689,
and tsc0280570 are only 1, 1, 3, and 1, respectively.
Rather, the departures from HWE are due to differential
no-calls in the Affymetrix platform. Compared to their
Illumina counterparts (where genotypes are reported for
all 245 unrelated individuals for each SNP), the number
of no-calls for tsc0546488, tsc1018661, tsc0039689, and
tsc0280570 are 51, 25, 18, and 28. For the first 3 SNPs all
of the no-calls were for genotypes called heterozygous in
the Illumina platform; for the fourth SNP, all of the no-
calls were for genotypes called 1/1 by Illumina. Accord-
ingly, it is the nonrandomness of the no-calls that leads to
the departure from HWE for these 4 Affymetrix SNPs.
We also searched for evidence of multiple recombinants.
We limited our analysis to rs958883/tsc0260848 in White
families, since this SNP gave the largest number of dis-
crepancies between the two platforms. SNP rs958883 is
marker 180 on Illumina's chromosome 5 map. The 12
White families with discrepancies for this SNP contained
a total of 186 meioses. We used the COUNT REC option
in GENEHUNTER version 2.1 [1] to infer the positions of
recombination for all of the markers on this chromosome.
We first analyzed all 276 markers in the Illumina set using
the genetic map provided by the company. We then sub-
stituted the tsc0260848 genotypes from the Affymetrix
platform for the rs958883 genotypes and repeated the
analysis. Finally, we deleted rs958883/tsc0260848 alto-
gether and repeated the analysis a third time. Figure 1
plots the results obtained by subtracting the inferred
number of recombinants in each interval (when the
inconsistent marker is removed), from the inferred
number of recombinants when the Illumina genotypes
(blue curve) or the Affymetrix genotypes (red curve) are
included. There is an unmistakable region of increased
recombination in the vicinity of the marker 180 when the
Affymetrix genotypes are used. Figure 1's inset shows that
the largest number of inferred recombinants occurs in the
expected interval. Two upstream peaks also occur due to
stretches of uninformative markers in some families.
While subroutines such as COUNT REC estimate the total
number of recombinants in an interval, other subroutines
are useful for inferring double recombinants in an indi-
vidual. We used GENEHUNTER's HAPLOTYPE option
and MERLIN's version 0.9.12b [2] best option to inspect
the inferred haplotypes in the core nuclear family of ped-
igree 10043. Individuals 10000432, 10000635, and
10000804 were genotyped as heterozygotes with the Illu-
mina platform and as 2/2 homozygotes with the Affyme-
trix platform. Figure 2 shows the GENEHUNTER output
of the core pedigree for SNP markers 175–185. All geno-
types are from Illumina except the middle marker, where
the genotypes from Affymetrix have been substituted for
rs958883. GENEHUNTER and MERLIN gave identical
inferences for this pedigree. Both identified 3 double
recombinants in adjacent intervals-namely intervals 179–
180 and 180–181. When the Illumina genotypes are used,
no double recombinants are inferred by either GENE-
HUNTER or MERLIN. (NB: in both the raw and the
cleaned Illumina data set, the mother's (10001581) geno-
type at rs958883 is recorded as 1/1 whereas in the raw and
the cleaned Affymetrix data set, the mother's genotype at
tsc0260848 is recorded as 1/1 and 0/0, respectively.) The
identified double recombinants occur in individuals
whose genotypes are consistent between the two plat-
forms. There are 2 equally probable inferences: either off-
spring 10000170, 1000060, and 10001543 (all of whom
are genotyped as 1/1 with both platforms) are double
recombinants and offspring 10000432, 10000635, and
10000804 (all of whom are genotyped as 2/2 with the
Affymetrix platform) are not double recombinants, or vice
versa. The evidence suggests that the 2/2 genotypes give
rise to the apparent double recombinations.
Discussion
There is remarkable agreement for SNP genotypes called
with the Illumina and Affymetrix platforms. The concord-
ance is estimated to be 99.85%. However, there is a sub-
stantially higher no-call rate with the Affymetrix platform
and the no-call rate appears to be genotype- and SNP-spe-
cific. This differential no-call rate gave rise to 4 (13%) sig-BMC Genetics 2005, 6:S152
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nificant departures from HWE in 32 SNPs that showed
one or more discrepancy between the two platforms. The
SNP that showed the largest number of discrepancies
(rs958883 in the Illumina dataset and tsc0260848 in the
Affymetrix dataset) was analyzed to determine if the pres-
ence of double recombinants could help resolve the dif-
ferences. Analysis of recombination in 12 White families
gave persuasive evidence of increased recombination
using the Affymetrix genotypes but no increase using the
Illumina genotypes. Analysis of a single family that con-
tained 3 offspring with the disputed genotype identified 3
double recombinants using the Affymetrix genotypes but
none with the Illumina genotypes.
The clustering of discrepancies within families is consist-
ent with the hypothesis that there is another SNP or inser-
tion/deletion that obliterates an XbaI site in the vicinity of
rs958883/tsc026848, thereby resulting in a fragment that
is too large to amplify. The closest 5' and 3' XbaI sites are
located 134 nucleotides upstream and 519 nucleotides
downstream. When both of these XbaI sites are intact, the
resulting fragment is within the size range (250–1,000 bp)
that can be amplified using common adapters. For
rs958883/tsc0260848, NCBI's dbSNP (build 123) indi-
cates that there is, indeed, another SNP (rs17150546) in
the closest upstream XbaI site that changes the wild-type
sequence (TCTAGA) to TCGAGA. When this XbaI site is
obliterated, the resulting fragment is 3,617 nucleotides-
clearly too long to be amplified. It is perhaps of interest
that the SNP that gave the second highest number of dis-
crepancies, rs768224/tsc0075731, also has a SNP
(rs10977965) in its neighboring XbaI site. When the
minor allele is present at this SNP, the resulting fragment
is 2,978 nucleotides in length- again, too long to be
amplified. Accordingly, these two known SNPs in XbaI
sites would account for 32% of the 180 observed discrep-
ancies. Of course, a definitive test of this hypothesis
would require sequencing discrepant individuals at the
respective XbaI sites.
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Inferred haplotypes for markers 175 to 185 for the core part  of pedigree 10043 Figure 2
Inferred haplotypes for markers 175 to 185 for the 
core part of pedigree 10043. Italics indicated that geno-
types were reconstructed. 'x' marks the interval where a 
recombinant is inferred to have occurred. The actual double 
recombinants are probably persons 10000432, 10000635, 
and 10000804 for reasons given in the text. The physical dis-
tance between the SNPs flanking the double recombinants is 
1.57 Mb.
Distribution of excess recombinants Figure 1
Distribution of excess recombinants. The red curve 
uses the Affymetrix genotype (tsc0260848) at marker 180. 
The blue curve uses the Illumina genotype (rs958883) at 
marker 180. The inset shows an enlarged view of the excess 
number of inferred recombinants in the neighborhood of 
rs958883/tsc0260848.
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